Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel NCCAM SEP ZAT1 K-02.
Date: January 4, 2002.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: 2 Democracy Plaza, 6707 Democracy Boulevard, Conference Room 701, Bethesda, MD 20892.
Contact Person: William A. Kachadorian, PhD., Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, 6707 Democracy Blvd, Ste 106, Bethesda, MD 20892-5475, (301) 594-2014, firstname.lastname@example.org.Start Signature
Dated: December 10, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-31047 Filed 12-17-01; 8:45 am]
BILLING CODE 4140-01-M